MUMBAI, April 24 -- Inventurus Knowledge Solutions (IKS Health) aims to be the leader in the US rural healthcare outsourcing market after its acquisition of TruBridge on Thursday, its top executive sa... Read More
MUMBAI, April 23 -- Jhunjhunwala family-backed Inventurus Knowledge Solutions (IKS Health) on Thursday announced the acquisition of US-based TruBridge Inc, a Nasdaq-listed provider of healthcare techn... Read More
New Delhi, April 23 -- Billionaire Azim Premji's investment firm Premji Invest has invested an undisclosed sum in NewEra Hospitals to scale the multispecialty hospital chain across Maharashtra, the fi... Read More
New Delhi, April 23 -- The number of overseas acquisitions by Indian drug companies has been steadily rising and is expected to continue growing as they scale up their ambitions, driven by a desire to... Read More
New Delhi, April 16 -- A 34-year-old Pune woman, diagnosed with polycystic ovary syndrome (PCOS) as a teenager, saw her first natural menstrual cycle in February-six months after starting Mounjaro for... Read More
MUMBAI, April 15 -- Singapore-based private equity firm Everstone Capital will invest close to $270 million for a significant stake in Apothecon Group, which includes India-based Apothecon and US-base... Read More
MUMBAI, April 14 -- Singapore-based private equity firm Everstone Capital will invest close to $270 million for a significant stake in Apothecon Group, which includes India-based Apothecon and US-base... Read More
New Delhi, April 7 -- A new variant of covid-19, called BA.3.2, has surfaced in several countries, highlighting yet again the virus's ability to continue mutating. While early reports point to a high ... Read More
New Delhi, April 1 -- On Tuesday, Danish drugmaker Novo Nordisk slashed prices of its blockbuster weight-loss and type-2 diabetes drugs Ozempic and Wegovy by up to 48%, as it faces mounting pressure f... Read More
Mumbai, March 31 -- Innovator Novo Nordisk on Tuesday said it is reducing the starting dose prices for its semaglutide brands Ozempic and Wegovy by 36% and 48%, respectively. It will also offer an ave... Read More